| Absorption | 
      | Blood-Brain Barrier | BBB+ | 0.8759 | 
      | Human Intestinal Absorption | HIA+ | 0.6909 | 
      | Caco-2 Permeability | Caco2- | 0.6591 | 
      | P-glycoprotein Substrate | Non-substrate | 0.8334 | 
      | P-glycoprotein Inhibitor | Non-inhibitor | 0.9923 | 
                                                     | Non-inhibitor | 0.9900 | 
      | Renal Organic Cation Transporter | Non-inhibitor | 0.9596 | 
        
            | Distribution | 
        
      | Subcellular localization | Mitochondria | 0.7983 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.8520 | 
      | CYP450 2D6 Substrate | Non-substrate | 0.8959 | 
      | CYP450 3A4 Substrate | Non-substrate | 0.7965 | 
      | CYP450 1A2 Inhibitor | Non-inhibitor | 0.9092 | 
      | CYP450 2C9 Inhibitor | Non-inhibitor | 0.9076 | 
        | CYP450 2D6 Inhibitor | Non-inhibitor | 0.9462 | 
      | CYP450 2C19 Inhibitor | Non-inhibitor | 0.9377 | 
      | CYP450 3A4 Inhibitor | Non-inhibitor | 0.9607 | 
      | CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9871 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9678 | 
                                                                    | Non-inhibitor | 0.9839 | 
      | AMES Toxicity | Non AMES toxic | 0.9365 | 
      | Carcinogens | Non-carcinogens | 0.5722 | 
      | Fish Toxicity | High FHMT | 0.6520 | 
      | Tetrahymena Pyriformis Toxicity | Low TPT | 0.9588 | 
      | Honey Bee Toxicity | High HBT | 0.7502 | 
      | Biodegradation | Ready biodegradable | 0.9382 | 
      | Acute Oral Toxicity | III | 0.5544 | 
      | Carcinogenicity (Three-class) | Non-required | 0.7104 |